RECRUITINGOBSERVATIONAL
Design of an Integrative Algorithm for Staging Tuberculosis
Design of an Integrative Algorithm for Staging Tuberculosis to Improve Clinical Management.
About This Trial
Tuberculosis is a chronic infectious disease that affects 10 million people, 300 in the city of Barcelona, every year. With serious consequences at public health level, it is associated with other diseases, and generated and influenced by many social and psychological factors. This study aims to stage tuberculosis disease by an integrative approach.
Who May Be Eligible (Plain English)
Who May Qualify:
- TB diagnosis (all forms), microbiologically confirmed (by AFB+, GenXpert+ or Culture+)
- Clinical management of the patients being done at Servicios Clínicos, Hospital Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans Trias i Pujol.
Who Should NOT Join This Trial:
- Not consenting to data/samples donation
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* TB diagnosis (all forms), microbiologically confirmed (by AFB+, GenXpert+ or Culture+)
* Clinical management of the patients being done at Servicios Clínicos, Hospital Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans Trias i Pujol.
Exclusion Criteria:
* Not consenting to data/samples donation
Locations (5)
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain
Hospital Sant Joan de Déu
Esplugues de Llobregat, Barcelona, Spain
Hospital del Mar
Barcelona, Spain
Hospital Universitari Vall d'Hebron-Drassanes
Barcelona, Spain
Servicios Clínicos de Barcelona
Barcelona, Spain